Expression of mineralocorticoid receptor and 11-beta-hydroxysteroid dehydrogenase type 2 in human atria during chronic atrial fibrillation: Study of 25 cases

National Medical Journal of China

Volumn 87, Issue 12, 2007, Pages 816-819

  Pei, De An ^a   Li, Li ^a   Xu, Zhi Yun ^a   Zou, Liang Jian ^a   Zhang, Bao Ren ^a   Huang, Sheng Dong ^a   Hao, Jia Hua ^a   Wang, Zhi Nong ^a   Lu, Fang Lin ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

11 beta hydroxysteroid dehydrogenase type 2; Atrial fibrillation; Mineralocorticoid receptor

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; MESSENGER RNA; MINERALOCORTICOID RECEPTOR;

ADULT; AORTA VALVE REPLACEMENT; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HEART MUSCLE; HEART RIGHT ATRIUM; HEART SIZE; HUMAN; HUMAN TISSUE; MALE; MITRAL VALVE REPLACEMENT; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RHEUMATIC HEART DISEASE; SINUS RHYTHM; TRANSTHORACIC ECHOCARDIOGRAPHY; UPREGULATION; WESTERN BLOTTING;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; ADULT; ATRIAL FIBRILLATION; BLOTTING, WESTERN; CHRONIC DISEASE; FEMALE; GENE EXPRESSION; HEART ATRIA; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; RECEPTORS, MINERALOCORTICOID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 34249808232     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Healey JS, Morillo CA, Connoolly SJ. Role of the renin-angiotensin-aldosterone system in atrial fibrillation and cardiac remodeling. Cur Opin Cardiol, 2005, 20:31-37.
2. Yoshida M, Ma J, Tomita T, et al. Mineralocorticoid receptor is overexpressed in cardiomyocytes of patients with congestive heart failure. Congest Heart Fail, 2005, 11: 12-16.
3. Pitt B, Zannad F, Remme, WJ, et al. The effects of spironnlactone on morbidity and mortality in patients with severe heart failure. Randomized Aldoctone Evaluation Study Investigator. N Engl J Med, 1999, 341: 709-717.
4. Pitt B, Remme W, Zannad F, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med, 2003, 348: 1309-1321.
5. Farman N, Bocchi B. Mineralocorticoid selectivity: molecular and cellular aspects. Kindney Int, 2000, 57: 1364-1369.
6. Goette A, Haffmanns P, Enayati W, et al. Effect of successful electrical cardioversion on serum aldosterone in patients with persistent atrial fibrillation. Am J Cardiol, 2001, 88: 906-909.
7. Kwak SP, Patel PD, Thompson RC, et al. 5′-Heterogeneity of the mineralocorticoid receptor for messenger ribonucleic acid: differential expression and regulation of splice variants within the rat hippocampus. Endocrinology, 1993, 133: 2344-2350.
8. Zennaro MC, LeMenuet D, Lombes M. Characterization of the human mineralocorticoid receptor gene 5′-regulatory region: evidence for differential hormonal regulation of two alternative promoters via nonclassical mechanism. Mol Endocrinol, 1996, 10: 1549-1560.
9. Robert V, Heymes C, Silvestre JS, et al. Angiotensin AT1 receptor subtype as a cardiac target of aldosterone: role in aldosterone-salt induced fibrosis. Hypertension, 1999, 33: 981-986.
10. Harada E, Yoshimura M, Yasue H, et al. Aldosterone induces angiotensin-converting-enzyme gene expression in cultured neonatal rat cardiocytes. Circulation, 2001, 104: 137-139.
11. Draper N, Stewart PM. 11β-Hydroxysteroid dehydrogenase and the pro-receptor regulation of corticosteroid hormone action. J Endocrinol, 2005, 186: 251-271.
12. Qin W, Rudolph AE, Bond BR, et al. Transgenic model of aldosterone-driven cardiac hypertrophy and heart failure. Circ Res, 2003, 93: 69-76.
13. Jaffe IZ, Mendelsohn ME. Angiotensin II and aldosterone regulate gene transcription via functional mineralocorticoid receptor in human coronary artery smooth muscle cells. Circ Res, 2005, 96: 643-650.